Sonoma Pharmaceuticals In...

2.86
-0.28 (-8.92%)
At close: Mar 27, 2025, 3:59 PM
2.88
0.74%
After-hours: Mar 27, 2025, 07:12 PM EDT

Sonoma Pharmaceuticals Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
Revenue 12.73M 13.27M 12.63M 18.63M 18.94M 18.97M 16.66M 12.82M 15.08M 13.85M 13.67M 15.45M 12.74M 9.75M 7.36M 5.39M 3.83M 4.54M 2.58M 1.36M 902K 2.47M 2M
Cost of Revenue 7.99M 8.79M 8.63M 12.07M 10.6M 10.09M 9.35M 7.16M 7.87M 6.57M 5.27M 4.71M 4.03M 3.61M 3.49M 2.59M 2.75M 3M 4.9M 3.52M n/a 1.77M 815K
Gross Profit 4.75M 4.48M 3.99M 6.56M 8.33M 8.88M 7.31M 5.67M 7.21M 7.29M 8.4M 10.74M 8.71M 6.14M 3.88M 2.8M 1.08M 1.54M -2.32M -2.17M 902K 702K 1.19M
Operating Income -4.7M -4.57M -5.89M -3.45M -6.67M -11.26M -14.19M -12.97M -10.15M -6.66M -6.05M -3.37M -6.47M -7.5M -8.02M -17.31M -22.43M -19.48M -20.85M -16.31M 902K -1.47M -147K
Interest Income n/a 16K 10K 16K 50K 190K 258K 22K 2K 1K 1K 7K 4K 3K 2K 152K n/a n/a n/a n/a n/a n/a n/a
Pretax Income -5.03M -5.18M -5.42M -3.9M -2.83M -11.34M -14.33M -12.94M -10.16M -8.2M 3.73M -5.43M -7.33M -7.95M -8.23M -17.66M -20.34M -19.78M -21.23M -16.17M n/a -1.47M -143K
Net Income -4.83M -5.15M -5.09M -4.62M -2.95M -11.8M -14.33M 9.27M -10.16M -8.2M 3.73M -5.43M -7.33M -7.95M -8.23M -17.66M -20.34M -19.78M -23.1M -16.53M -7.3M -1.59M -167K
Selling & General & Admin 7.58M 8.84M 9.76M 9.45M 13.66M 18.62M 19.92M 17.07M 15.56M 12.41M 11.56M 11.89M 13.2M 11.6M 9.9M 13.86M 13.73M 16.52M 15.93M 12.49M n/a 2.1M 1.33M
Research & Development 1.87M 207K 125K 555K 1.34M 1.52M 1.57M 1.58M 1.81M 1.53M 2.89M 2.22M 1.98M 2.05M 2M 6.25M 9.78M 4.51M 2.6M 1.65M n/a 68K 6K
Other Expenses n/a -631K -394K -594K 240K -239K -357K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 9.45M 9.05M 9.88M 10.01M 15M 20.14M 21.5M 18.64M 17.36M 13.95M 14.45M 14.12M 15.18M 13.65M 11.89M 20.11M 23.51M 21.03M 18.53M 14.15M n/a 2.17M 1.33M
Interest Expense n/a 16K 10K 12K 16K 33K 40K 3K 3K 3K 1.06M 1.11M 931K 406K 9K 437K n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses 156K 156K 86K 41K 35K 157K 177K 149K 175K 231K 155K 91K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 17.44M 17.84M 18.52M 22.08M 25.61M 30.23M 30.85M 25.8M 25.24M 20.51M 19.72M 18.83M 19.21M 17.26M 15.38M 22.7M 26.26M 24.03M 23.43M 17.67M n/a 3.94M 2.15M
Income Tax -196K -33K -332K 713K 121K 458K -807K -4.27M -241K -250K 774K 839K 862K 443K -217K 349K -2.09M 299K 2.25M 218K 8.04M 123K 24K
Shares Outstanding (Basic) 909K 339.4K 265.3K 199.6K 147.7K 92.4K 50.33K 46.93K 7.31K 21.46K 15.29K 11.06K 8.69K 8.37K 7.3K 5.15K 4.04K 1.73K 3.63K 3.63K 2.48K 2.43K 2.41K
Shares Outstanding (Diluted) 909K 339.4K 265.3K 199.6K 147.7K 92.4K 50.33K 46.93K 7.31K 21.46K 15.33K 11.06K 8.69K 8.37K 7.3K 5.15K 4.04K 1.73K 3.63K 3.63K 2.48K 2.43K 2.41K
EPS (Basic) -5.32 -15.18 -19.17 -23.65 -22.4 -127.68 -284.66 -221.7 -1.39K -382.5 243.00 -585.02 -850.5 -945 -1.13K -3.43K -5.04K -11.69K -5.83K -4.57K -2.94K -656.45 -69.3
EPS (Diluted) -5.32 -15.18 -19.17 -23.65 -22.4 -127.68 -284.66 -221.7 -1.39K -382.5 243.00 -585.02 -850.5 -945 -1.13K -3.43K -5.04K -11.69K -5.83K -4.57K -2.94K -656.45 -69.3
EBITDA -4.53M -4.45M -5.7M -3.22M -3.22M -10.85M -13.8M -12.69M -14.48M -7.95M -5.77M -4.06M -6.07M -7.15M -7.79M -16.45M -22.43M -18.81M -20.2M -15.88M 902K -1.46M -151K
Depreciation & Amortization 176K 298K 409K 227K 312K 453K 490K 248K 244K 253K 284K 268K 326K 395K 433K 768K 740K 672K 651K 434K 160K 4K -4K